Protara Therapeutics Stock Price History
| TARA Stock | USD 2.94 0.34 13.08% |
Below is the normalized historical share price chart for Protara Therapeutics extending back to October 22, 2014. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of Protara Therapeutics stands at 2.94, as last reported on the 27th of November, with the highest price reaching 3.00 and the lowest price hitting 2.60 during the day.
If you're considering investing in Protara Stock, it is important to understand the factors that can impact its price. Protara Therapeutics appears to be very risky, given 3 months investment horizon. Protara Therapeutics maintains Sharpe Ratio (i.e., Efficiency) of 0.16, which implies the firm had a 0.16% return per unit of risk over the last 3 months. By analyzing Protara Therapeutics' technical indicators, you can evaluate if the expected return of 0.68% is justified by implied risk. Please evaluate Protara Therapeutics' Risk Adjusted Performance of 0.1147, coefficient of variation of 717.84, and Semi Deviation of 2.77 to confirm if our risk estimates are consistent with your expectations.
At present, Protara Therapeutics' Total Stockholder Equity is projected to increase significantly based on the last few years of reporting. The current year's Common Stock Total Equity is expected to grow to about 12.9 K, whereas Other Stockholder Equity is forecasted to decline to about 237.6 M. . The current year's Price Earnings To Growth Ratio is expected to grow to 0.01, whereas Price To Sales Ratio is forecasted to decline to 8.65. Protara Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
IPO Date 22nd of October 2014 | 200 Day MA 2.6632 | 50 Day MA 2.111 | Beta 1.786 |
Protara |
Sharpe Ratio = 0.1565
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | TARA | |||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 4.33 actual daily | 38 62% of assets are more volatile |
Expected Return
| 0.68 actual daily | 13 87% of assets have higher returns |
Risk-Adjusted Return
| 0.16 actual daily | 12 88% of assets perform better |
Based on monthly moving average Protara Therapeutics is performing at about 12% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Protara Therapeutics by adding it to a well-diversified portfolio.
Price Book 0.7415 | Book Value 6.012 | Enterprise Value -16.1 M | Enterprise Value Ebitda 0.7403 | Shares Float 15.2 M |
Protara Therapeutics Stock Price History Chart
There are several ways to analyze Protara Stock price data. The simplest method is using a basic Protara candlestick price chart, which shows Protara Therapeutics price history and the buying and selling dynamics of a specified period. Many traders also use subjective judgment to their trading calls, avoiding the need to trade based on technical analysis.
| Highest Price | November 26, 2024 | 2.94 |
| Lowest Price | October 10, 2024 | 1.62 |
Protara Therapeutics November 27, 2024 Stock Price Synopsis
Various analyses of Protara Therapeutics' daily price changes, such as its Balance Of Power or Price Action, are crucial when deciding whether to buy, hold, or sell Protara Stock. It can be used to describe the percentage change in the price of Protara Therapeutics from one trading day to the next and could be a valuable metric for traders and investors to gauge the volatility and momentum of Protara Stock.| Protara Therapeutics Price Daily Balance Of Power | 0.85 | |
| Protara Therapeutics Price Rate Of Daily Change | 1.13 | |
| Protara Therapeutics Price Action Indicator | 0.31 |
Protara Therapeutics November 27, 2024 Stock Price Analysis
Protara Stock Price History Data
The price series of Protara Therapeutics for the period between Thu, Aug 29, 2024 and Wed, Nov 27, 2024 has a statistical range of 1.32 with a coefficient of variation of 15.7. The price distribution for the period has arithmetic mean of 2.08. The median price for the last 90 days is 1.93. The company completed stock split (1:40) on 10th of January 2020. Protara Therapeutics had dividends distributed to its stock-holders on 2020-01-10.| Open | High | Low | Close | Volume | ||
11/27/2024 | 2.66 | 3.00 | 2.60 | 2.94 | ||
| 11/26/2024 | 2.66 | 3.00 | 2.60 | 2.94 | 289,135 | |
| 11/25/2024 | 2.42 | 2.66 | 2.36 | 2.60 | 125,878 | |
| 11/22/2024 | 2.32 | 2.45 | 2.31 | 2.39 | 99,800 | |
| 11/21/2024 | 2.34 | 2.40 | 2.28 | 2.29 | 64,860 | |
| 11/20/2024 | 2.30 | 2.34 | 2.28 | 2.31 | 26,903 | |
| 11/19/2024 | 2.30 | 2.34 | 2.21 | 2.32 | 121,035 | |
| 11/18/2024 | 2.47 | 2.53 | 2.30 | 2.31 | 151,316 | |
| 11/15/2024 | 2.57 | 2.60 | 2.42 | 2.47 | 273,210 | |
| 11/14/2024 | 2.78 | 2.78 | 2.55 | 2.58 | 217,919 | |
| 11/13/2024 | 2.61 | 2.78 | 2.60 | 2.69 | 212,789 | |
| 11/12/2024 | 2.51 | 2.67 | 2.51 | 2.58 | 139,865 | |
| 11/11/2024 | 2.60 | 2.66 | 2.51 | 2.58 | 90,017 | |
| 11/08/2024 | 2.54 | 2.57 | 2.45 | 2.54 | 112,940 | |
| 11/07/2024 | 2.48 | 2.56 | 2.45 | 2.54 | 129,013 | |
| 11/06/2024 | 2.72 | 2.72 | 2.43 | 2.45 | 157,646 | |
| 11/05/2024 | 2.61 | 2.74 | 2.56 | 2.61 | 262,505 | |
| 11/04/2024 | 2.49 | 2.60 | 2.44 | 2.59 | 167,743 | |
| 11/01/2024 | 2.54 | 2.55 | 2.34 | 2.47 | 242,126 | |
| 10/31/2024 | 2.38 | 2.53 | 2.27 | 2.51 | 162,975 | |
| 10/30/2024 | 2.32 | 2.44 | 2.25 | 2.34 | 99,393 | |
| 10/29/2024 | 2.39 | 2.39 | 2.21 | 2.34 | 122,216 | |
| 10/28/2024 | 2.27 | 2.42 | 2.25 | 2.40 | 351,862 | |
| 10/25/2024 | 1.99 | 2.35 | 1.96 | 2.26 | 679,045 | |
| 10/24/2024 | 1.87 | 2.04 | 1.80 | 2.00 | 267,531 | |
| 10/23/2024 | 1.88 | 1.92 | 1.78 | 1.88 | 137,560 | |
| 10/22/2024 | 2.05 | 2.05 | 1.87 | 1.91 | 208,322 | |
| 10/21/2024 | 1.95 | 2.19 | 1.87 | 2.01 | 668,828 | |
| 10/18/2024 | 1.86 | 1.93 | 1.77 | 1.91 | 171,327 | |
| 10/17/2024 | 1.87 | 1.96 | 1.78 | 1.85 | 169,651 | |
| 10/16/2024 | 1.79 | 1.88 | 1.79 | 1.86 | 71,261 | |
| 10/15/2024 | 1.80 | 1.84 | 1.75 | 1.79 | 46,978 | |
| 10/14/2024 | 1.70 | 1.85 | 1.68 | 1.82 | 123,897 | |
| 10/11/2024 | 1.62 | 1.76 | 1.62 | 1.68 | 151,527 | |
| 10/10/2024 | 1.68 | 1.75 | 1.60 | 1.62 | 120,870 | |
| 10/09/2024 | 1.72 | 1.75 | 1.68 | 1.69 | 79,585 | |
| 10/08/2024 | 1.75 | 1.84 | 1.71 | 1.74 | 60,606 | |
| 10/07/2024 | 1.80 | 1.89 | 1.73 | 1.76 | 89,685 | |
| 10/04/2024 | 1.77 | 1.83 | 1.74 | 1.79 | 74,950 | |
| 10/03/2024 | 1.76 | 1.81 | 1.73 | 1.76 | 61,161 | |
| 10/02/2024 | 1.76 | 1.82 | 1.75 | 1.77 | 238,186 | |
| 10/01/2024 | 1.82 | 1.83 | 1.75 | 1.78 | 110,498 | |
| 09/30/2024 | 2.08 | 2.08 | 1.79 | 1.83 | 275,868 | |
| 09/27/2024 | 1.83 | 1.90 | 1.82 | 1.89 | 84,911 | |
| 09/26/2024 | 1.83 | 1.92 | 1.81 | 1.83 | 96,651 | |
| 09/25/2024 | 1.81 | 1.90 | 1.80 | 1.83 | 84,979 | |
| 09/24/2024 | 1.90 | 1.90 | 1.76 | 1.80 | 85,317 | |
| 09/23/2024 | 1.98 | 2.00 | 1.87 | 1.89 | 228,215 | |
| 09/20/2024 | 1.97 | 1.99 | 1.89 | 1.98 | 136,113 | |
| 09/19/2024 | 2.00 | 2.02 | 1.95 | 1.97 | 75,267 | |
| 09/18/2024 | 1.83 | 2.02 | 1.83 | 1.92 | 199,138 | |
| 09/17/2024 | 1.87 | 1.96 | 1.81 | 1.82 | 86,220 | |
| 09/16/2024 | 1.91 | 1.92 | 1.81 | 1.87 | 77,835 | |
| 09/13/2024 | 1.77 | 1.89 | 1.75 | 1.88 | 242,806 | |
| 09/12/2024 | 1.71 | 1.77 | 1.69 | 1.73 | 323,681 | |
| 09/11/2024 | 1.73 | 1.77 | 1.68 | 1.70 | 182,151 | |
| 09/10/2024 | 1.83 | 1.85 | 1.69 | 1.73 | 250,380 | |
| 09/09/2024 | 1.88 | 1.97 | 1.80 | 1.84 | 209,789 | |
| 09/06/2024 | 1.89 | 1.98 | 1.81 | 1.86 | 129,635 | |
| 09/05/2024 | 1.92 | 1.97 | 1.89 | 1.90 | 108,899 | |
| 09/04/2024 | 1.90 | 1.99 | 1.86 | 1.93 | 167,812 |
About Protara Therapeutics Stock history
Protara Therapeutics investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Protara is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Protara Therapeutics will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Protara Therapeutics stock prices may prove useful in developing a viable investing in Protara Therapeutics
| Last Reported | Projected for Next Year | ||
| Common Stock Shares Outstanding | 11.3 M | 11.9 M | |
| Net Loss | -59.4 M | -56.4 M |
Protara Therapeutics Quarterly Net Working Capital |
|
Protara Therapeutics Stock Technical Analysis
Protara Therapeutics technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Did you try this?
Run Positions Ratings Now
Positions RatingsDetermine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance |
| All Next | Launch Module |
Protara Therapeutics Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Protara Therapeutics' price direction in advance. Along with the technical and fundamental analysis of Protara Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Protara to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | 0.1147 | |||
| Jensen Alpha | 0.5617 | |||
| Total Risk Alpha | (0.09) | |||
| Sortino Ratio | 0.1458 | |||
| Treynor Ratio | 2.51 |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Complementary Tools for Protara Stock analysis
When running Protara Therapeutics' price analysis, check to measure Protara Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Protara Therapeutics is operating at the current time. Most of Protara Therapeutics' value examination focuses on studying past and present price action to predict the probability of Protara Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Protara Therapeutics' price. Additionally, you may evaluate how the addition of Protara Therapeutics to your portfolios can decrease your overall portfolio volatility.
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing |